Medtech titan Medtronic says that it's not involved with research on an orgasm-inducing neurostimulation system, despite reports to the contrary.
Medical device industry giant Medtronic (NYSE:MDT) told MassDevice.com today that despite reports of the company's participation in upcoming studies, Medtronic is not involved with research on an implantable neurostimulator designed for treatment of sexual dysfunction.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Analogic is on track with layoffs and facilities closures announced last year, but ALOG shares dive after the company reports disappointing earnings for its 2nd quarter and projects flat progress for the year ahead.